Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2 | NEJM
posted 1 day
Mashup Score: 87
New England Journal of Medicine (NEJM) - Correspondence from The New England Journal of Medicine — Delayed Large Local Reactions to mRNA-1273 Vaccine against...
Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2 | NEJM
posted 1 day
Mashup Score: 25
New England Journal of Medicine (NEJM) - Correspondence from The New England Journal of Medicine — Delayed Large Local Reactions to mRNA-1273 Vaccine against...
Delayed skin reactions at the injection site following #COVID19 vaccination, appearing ~day 8. Looks like this happens in ~0.8% after 1st dose, and ~0.2% after 2nd dose. https://t.co/EgQPh1Y2zN https://t.co/EgQPh1Y2zN
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma | NEJM
posted 1 day
Mashup Score: 8
New England Journal of Medicine (NEJM) - Original Article from The New England Journal of Medicine — Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell...
Just in @NEJM :practice changing results in mRCC #kidneycancer 👉Remarkably improved OS, PFS, ORR with Cabozantinib + nivolumab versus sunitinib. QOL was also improved with the combo. Congrats to @DrChoueiri @motzermd @tompowles1 OncoAlert @urotoday https://t.co/KaB22Rn0Te 👇 https://t.co/KaB22Rn0Te
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine | NEJM
posted 1 day
Mashup Score: 8
New England Journal of Medicine (NEJM) - Original Article from The New England Journal of Medicine — Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19...
Great! Can you send me that slide? You know what that goes with? The increased immunogenicity (increasing immune response) in the phase I/II clinical trial of the J&J vaccine from days 29 to days 57 - see here. Great news. https://t.co/RHLOe6leWZ https://t.co/RHLOe6leWZ
New England Journal of Medicine (NEJM) - Review Article from The New England Journal of Medicine — Diffuse Large B-Cell...
Fabulous! Diffuse Large B-Cell Lymphoma | NEJM https://t.co/fBQmr11Lkr
Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2 | NEJM
posted 1 day
Mashup Score: 7
New England Journal of Medicine (NEJM) - Correspondence from The New England Journal of Medicine — Delayed Large Local Reactions to mRNA-1273 Vaccine against...
3/12 patients had recurrent reactions that were similar to those after the 1st dose 3/12 had recurrent reactions that were of a lower grade than after the 1st dose. The median onset of cutaneous symptoms after the second dose was 2 days (range, 1 to 3) https://t.co/rhxXMnhWQD
NEJM reports that #COVDArm has a median onset on day 8 (range, 4 to 11) after the first dose. The symptoms resolved a median of 6 days after onset (range, 2 to 11). https://t.co/rhxXMnhWQD
Here are pictures of #COVIDArm from 12 cases in the NEJM https://t.co/rhxXMnhWQD https://t.co/rhxXMnhWQD
Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2 | NEJM
posted 9 hours
Mashup Score: 4
New England Journal of Medicine (NEJM) - Correspondence from The New England Journal of Medicine — Delayed Large Local Reactions to mRNA-1273 Vaccine against...
great great work by my better half @KimberlyBlumen1 and colleagues @MGHAllergy! Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2 | NEJM https://t.co/gLeJUiMjdT
Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2 | NEJM
posted 1 day
Mashup Score: 4
New England Journal of Medicine (NEJM) - Correspondence from The New England Journal of Medicine — Delayed Large Local Reactions to mRNA-1273 Vaccine against...
Delayed skin reactions following #COVID19 vaccination, appearing ~day 8. Looks like this happens in ~0.8% after 1st dose, and ~0.2% after 2nd dose. https://t.co/EgQPh1Y2zN
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma | NEJM
posted 1 day
Mashup Score: 4
New England Journal of Medicine (NEJM) - Original Article from The New England Journal of Medicine — Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell...
Out📣on @NEJM 📰 Great paper by our Amazing @OncoAlert 🚨colleague @DrChoueiri 👨⚕️🇺🇸& CheckMate9️⃣ER Team ( @tompowles1 @apolo_andrea et al) Nivo➕cabo has significant benefits over sunitinib in #RCC ☑️PFS ☑️OS ☑️likelihood of response #KidneyCancer ‼️ https://t.co/cryIYBHBDQ https://t.co/cryIYBHBDQ
Conquering Atherosclerotic Cardiovascular Disease — 50 Years of Progress | NEJM
posted 10 hours
Mashup Score: 3
New England Journal of Medicine (NEJM) - Perspective from The New England Journal of Medicine — Conquering Atherosclerotic Cardiovascular Disease — 50 Years of...
Conquering Atherosclerotic Cardiovascular Disease — 50 Years of Progress | @NEJM Big HT to @AqamarMD ! https://t.co/QbmY0ADspK
Delayed, local injection-site reactions to vaccines are uncommon, likely T-cell mediated hypersensitivity, reported @NEJM today https://t.co/GtcJXNi6bv by @KimberlyBlumen1 @MGHMedicine and colleagues https://t.co/GtcJXNi6bv